Sanjuro wrote: » Sorry if this sounds a little confrontational, as its not what I'm trying to be. But how are you confident this will happen? I was quite confident that things would ramp up about a month ago, but recently I've become a bit more disillusioned with the constant AZ situation and seemingly constant number of shots being administered with no significant increase week on week. Things seem to have ground to a snail's pace. Am I reading the situation incorrectly? I certainly hope so.
Pete_Cavan wrote: » Yes I'm well aware of that, just wondering if those ranting would be happy for the EU to leave other countries short on vaccines.
[Deleted User] wrote: » The EU got caught out by some simple game theory. Being all high-minded and going for solidarity only works when all parties are on board. Once the other party isn't on board you're only shooting yourself in the face by continuing on the path. The Brits made it perfectly clear by the middle of last year they were going on their own, I naively assumed the EU would factor that into their decision making and policy going forward but it looks like they didn't.
NeuralNetwork wrote: » Mostly through the huge capacity coming in stream with BioNTech who’ve basically both purchased their own facility from Novartis (750m dose capacity), the existing Pfizer capacity being enhanced and they’ve also assembled a consortium of Sanofi & 12 other companies including Novartis to increase capacity. There’s more capacity coming on stream for Moderna via Lonza who manufactures for them. Then you’ve Janssen / J&J which is a viral vector vaccine developed by Janssen in Belgium and they’re a far bigger operation than AstraZeneca. Novavax is also due to arrive soon and you’ve a 3rd mRNA vaccine from CureVac, a second German biotech company who are tied up with Bayer for manufacturing. What’s going on in the background at the moment is primarily a huge ramping up of the BioNTech/ Pfizer vaccine production capacity and that’s being done both by Pfizer which is a huge operation itself and a consortium of other companies bringing in capacity too. A lot of this has been pot luck with which vaccines hit the market first & what capacity is there. AstraZeneca’s bumps in supply aren’t helping at all.
NeuralNetwork wrote: » EU based research has delivered the BioNTech vaccine, the CureVac vaccine and the Janssen vaccine. There are multinational efforts involved in production but that’s just the reality of pharma and biopharma. All of them are multinationals. If AstraZeneca’s acting primarily for the U.K. it’s surprising. It’s also a multinational with facilities in Europe and the USA and globally. It’s also a very international board and a French CEO. The company itself is also a product of a merger between Astra in Sweden & Zeneca which was the ICI pharmaceutical unit. For a company like that to act in a nationalistic manner makes little sense to me.
Danzy wrote: » That you imagine it is working in a nationalistic manner is strictly on you.
NeuralNetwork wrote: » And that you chose to read my post that way is strictly on you. My point is that it seems absurd that they could be acting in such way. I’m not the one making that suggestion. It looks to me more like they bit off a lot more than they can chew and in reality can’t meet an order the scale of the EU’s. They need to be more transparent about what’s going on though. What’s driven all this has been the last minute announcements of short supplies that have happened several times now.
brickster69 wrote: » Allowing a few extra months of sausage rolls on the shelves of Northern Ireland supermarkets is a serious breach of trust and law, but blocking the export of vaccines paid for by others in good faith is absolutely fine though.
brickster69 wrote: » VDL getting tough today.https://twitter.com/SkyNews/status/1372272776778776578
brickster69 wrote: » Would Ireland support an export ban that denies NI citizens vaccines from Europe ?
brickster69 wrote: » A bit pathetic really, especially when Pfizer and other makers rely on material from countries that would be blocked. Probably never thought about that yet.
NeuralNetwork wrote: » Novavax is also due to arrive soon and you’ve a 3rd mRNA vaccine from CureVac, a second German biotech company who are tied up with Bayer for manufacturing.
Sanjuro wrote: » Well that's told me! 😄 Thank you for such a comprehensive answer.
SnuggyBear wrote: » Anyone know when the 70s are expected to be finished now?
Melanchthon wrote: » It's also a pretty optimistic answer. The EU doesn't have a contract with Novaxax (and yes I know talks happen but publicly traded companies don't tend to keep massively beneficial for their company orders quiet).
eoinbn wrote: » I just don't understand why UVL is threatening to block supplies of Pfizer now - what has changed recently? Is it the AZ supply reduction or is something else at play?
astrofool wrote: » Pure speculation on my part as well, but it can't be a coincidence that vaccine supplies for the UK slow down on the same day the EU say they are looking at restricting exports. They've probably been watching a significant amount of AZ vaccine supply from Europe go to the UK since the close tracking started, and are taking steps against it (if the numbers are correct, 75% of the UK rollout has been EU produced supply). Cummings coming out and sticking the boot into the NHS today doesn't help either.
eoinbn wrote: » I don't think any AZ has moved from Europe since January. However it is believed that the Halix plant in the Netherlands was supplying the UK in December and maybe up until January. It takes 6 weeks to fill and finish. What we could be seeing in the UK is that some of their supply over the last 6 weeks was vaccine created in Halix, in January, but shipped to the UK for F&F. They would now be nearly out of the that supply. It would explain why AZ didn't asked for that plant to be approved by the EMA back in January. It might have been a key part of the UK supply chain. Then again maybe they just had a few bad batches...